These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Muscular complications in HIV infection]. Authier FJ; Chariot P; Gherardi R Arch Anat Cytol Pathol; 1997; 45(2-3):174-8. PubMed ID: 9382610 [TBL] [Abstract][Full Text] [Related]
9. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy. Espinoza LR; Aguilar JL; Espinoza CG; Gresh J; Jara J; Silveira LH; Martinez-Osuna P; Seleznick M Rheum Dis Clin North Am; 1991 Feb; 17(1):117-29. PubMed ID: 2041882 [TBL] [Abstract][Full Text] [Related]
10. [Zidovudine and human immunodeficiency virus infection: when and how to initiate treatment]. Corzo JE; Leal M Med Clin (Barc); 1991 Jun; 97(5):178-80. PubMed ID: 1921546 [No Abstract] [Full Text] [Related]
11. HIV or zidovudine myopathy? Gherardi R; Chariot P Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597 [No Abstract] [Full Text] [Related]
12. [Peripheral nerve diseases and myopathies associated with HIV infection]. Nervenarzt; 2000 Jun; 71(6):442-50. PubMed ID: 10919138 [TBL] [Abstract][Full Text] [Related]
14. Zidovudine-induced leukocytoclastic vasculitis. Torres RA; Lin RY; Lee M; Barr MR Arch Intern Med; 1992 Apr; 152(4):850-1. PubMed ID: 1558446 [TBL] [Abstract][Full Text] [Related]
15. Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine? Till M; MacDonell KB Ann Intern Med; 1990 Oct; 113(7):492-4. PubMed ID: 1975486 [No Abstract] [Full Text] [Related]
17. [Myopathies in the course of HIV infection]. Enting RH; Portegies P; de Visser M Ned Tijdschr Geneeskd; 1992 Jul; 136(30):1446-9. PubMed ID: 1331819 [No Abstract] [Full Text] [Related]